Youth Weigh In: Views on Advanced Neurotechnology for Drug-Resistant Epilepsy.
J Child Neurol
; 36(2): 128-132, 2021 02.
Article
em En
| MEDLINE
| ID: mdl-32942941
BACKGROUND: Epilepsy affects over 500,000 children in North America of whom 30% have drug-resistant epilepsy. Advancements with neurotechnologies show promising benefits, but the perceptions of these procedures by youth is unknown. METHODS: We conducted semistructured interviews with 10 youth in British Columbia, Canada who underwent procedures for drug-resistant epilepsy involving different forms of neurotechnology (subdural grids, vagus nerve stimulation, responsive neurostimulation). Interviews were analyzed using the constant comparative qualitative method. RESULTS: Four major thematic categories emerged from the interviews. Treatment values, impact of the disorder, personal context, and impact of neurotechnology. CONCLUSIONS: Besides the predictable goal of seizure reduction, a desire for autonomy and the importance of trust in the medical team emerged as dominant values within the 4 thematic categories that were explicit to the use of new neurotechnologies for the management of drug-resistant epilepsy.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Terapia por Estimulação Elétrica
/
Epilepsia Resistente a Medicamentos
Tipo de estudo:
Prognostic_studies
/
Qualitative_research
País/Região como assunto:
America do norte
Idioma:
En
Revista:
J Child Neurol
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Canadá